Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies

Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH‐specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; howeve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pulmonary circulation 2024-07, Vol.14 (3), p.e12419-n/a
Hauptverfasser: Staal, Diederik P., Hendriks, Paul M., Thor, Mitch C. J., Groep, Liza D., Toorn, Leon M., Mulder, Berend‐Jan M., Chandoesing, Prewesh P., Kauling, Robert M., Boerman, Sanne, Bosch, Annemien E., Mager, Johannes J., Boomars, Karin A., Post, Martijn C.
Format: Artikel
Sprache:eng
Schlagworte:
chronic thromboembolic pulmonary hypertension
Medical prognosis
prognosis
pulmonary embolism
Pulmonary hypertension
Research Letter
survival
Thromboembolism
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Therapies for inoperable chronic thromboembolic pulmonary hypertension (CTEPH) include balloon pulmonary angioplasty (BPA) and PH‐specific medical therapy. This study compares survival and its predictors before and after the introduction of BPA. BPA was independently associated with survival; however, there was no difference in overall survival between the two cohorts.
ISSN:2045-8940
2045-8932
2045-8940
DOI:10.1002/pul2.12419